Progress Software Sets $988M–$1B FY26 Revenue Target: Progress targets $988M–$1.0B for FY26 (announced Mar 30, 2026), a $12M guidance band (~1.2%) tied to AI-driven efficiencies and stated debt… 👈 Read full analysis #ProgressSoftware #RevenueTarget #FiscalYear2026 #AI #OperationalEfficiency
Progress Software Sets $988M–$1B FY26 Revenue Target
Progress targets $988M–$1.0B for FY26 (announced Mar 30, 2026), a $12M guidance band (~1.2%) tied to AI-driven efficiencies and stated debt reduction goals.
dlvr.it
March 31, 2026 at 12:42 AM
Progress Software Sets $988M–$1B FY26 Revenue Target: Progress targets $988M–$1.0B for FY26 (announced Mar 30, 2026), a $12M guidance band (~1.2%) tied to AI-driven efficiencies and stated debt… 👈 Read full analysis #ProgressSoftware #RevenueTarget #FiscalYear2026 #AI #OperationalEfficiency
Datavault AI Posts First Profitable Quarter, Sets 2026 Target: Datavault AI reported $1.9m net income for the quarter ended Mar 31, 2026 and set a $120m 2026 revenue target, per the Mar 29, 2026 company release… 👈 Read full analysis #DatavaultAI #Profit #RevenueTarget #FinancialNews #TechStartups
Datavault AI Posts First Profitable Quarter, Sets 2026 Target
Datavault AI reported $1.9m net income for the quarter ended Mar 31, 2026 and set a $120m 2026 revenue target, per the Mar 29, 2026 company release and Yahoo Finance.
dlvr.it
March 29, 2026 at 10:35 PM
Datavault AI Posts First Profitable Quarter, Sets 2026 Target: Datavault AI reported $1.9m net income for the quarter ended Mar 31, 2026 and set a $120m 2026 revenue target, per the Mar 29, 2026 company release… 👈 Read full analysis #DatavaultAI #Profit #RevenueTarget #FinancialNews #TechStartups
MaxCyte Sees $30M–$32M Revenue Target for 2026: MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive. 👈 Read full analysis #MaxCyte #RevenueTarget #ExPERTDTx #SPLMilestones #FinancialGoals
MaxCyte Sees $30M–$32M Revenue Target for 2026
MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive.
dlvr.it
March 25, 2026 at 6:32 AM
MaxCyte Sees $30M–$32M Revenue Target for 2026: MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive. 👈 Read full analysis #MaxCyte #RevenueTarget #ExPERTDTx #SPLMilestones #FinancialGoals
